Modern Therapy of Viral Hepatitis
DOI:
https://doi.org/10.62480/tjms.2023.vol26.pp66-69Keywords:
Etiotropic treatment, hepatitis, clinic, hepatitis, cliniAbstract
Viral hepatitis (VH) is a large group of diseases that differ in etiology, epidemiology, and clinical presentation with predominant liver damage. Currently, the following independent forms of VG are known, which are usually denoted by letters of the Latin alphabet: A, B, C, D, E, G, TTV. The greatest importance for practical health care is represented by hepatitis with parenteral (or hemocontact) infection and, above all, hepatitis caused by viruses B, C, D. This is due to the fact that when infected with these viruses, the course of the disease is usually more severe than with hepatitis A and E, lightning-fast (malignant) infections are possible
References
Abdulloyev M. Z. IN CHRONIC VIRAL HEPATITIS AND CIRRHOSIS OF THE LIVER, THE STUDY OF CYTOKINE LEVELS //BARQARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI. – 2022. – Т. 2. – №. 12. – С. 784-787.
Abdulloyev M. Z. The Study of Cytokine Levels in Chronic Viral Hepatitis and Liver Cirrhosis
Yershov F. I. Interferon system in normal and pathological conditions, Moscow: Meditsina Publ.,1998.
Yershov F. I., Tazulakhova E. B. Inductors of interferon - a new generation of immunomodulators / /Journal микробиолof Microbiology, 1996, No. 3, pp. 122-125.
Krel P. E. Antiviral therapy of chronic liver diseases // Russian Journal of Gastroenterology, hepatol and coloproctol. - 1997. - Vol. VII. - No. 1.
Malinovskaya V. V. Age-related features of antiviral protection and their correction with the complex drug "Viferon" in children with chronic viral liver diseases // Abstracts of reports of the II Russian
Vinogradova E. N. Viral hepatitis B and C (problems of diagnosis and therapy)Автореф. diss. doctorof Medical Sciences. St. Petersburg, 1997.
Goryacheva L. G. Cycloferon: an effective remedy for pediatrics. - SPb, 2002.
Oblokulov A. R., Husenova Z. Z., Ergashev M. M. Procalcitonin as an indicator of antibacterial therapy in covid-19 //Annals of the Romanian Society for Cell Biology. – 2021. – С. 5220-5224.
Oblokulov A. R., Niyozov G. E. Clinical and epidemiological characteristics of patients with COVID-19 //International Journal of Pharmaceutical Research. – 2020. – С. 3749-3752.
Oblokulov A. R., Niyozov G. E. Clinical and epidemiological characteristics of patients with COVID-19 //International Journal of Pharmaceutical Research. – 2020. – С. 3749-3752.
Облокулов А. Р. и др. АБУ АЛИ ИБН СИНА. СТРАНИЦЫ ЖИЗНИ ВЕЛИКОГО УЧЕНОГО //Новый день в медицине. – 2020. – №. 4. – С. 563-564.
Облокулов А. Р. и др. Особенности течения лямблиоза у взрослых //Инфекция, иммунитет и фармакология. – 1999. – С. 151-156.
Худойдодова С. Г., Арашова Г. А., Мирзоева М. Р. Вирусли гептит В лямблиоз билан кечган микстинфекцияда хужайра ва гуморал иммунитет курсаткичларининг патогенетик аҳамияти //Инфекция, иммунитет и фармакология. – 2011. – №. 1-2. – С. 103-110.
Mukhammadieva M.I. (2022). Modern Clinical and Biochemical Characteristics of Liver Cirrhosis Patients of Viral Etiology with Spontaneous Bacterial Peritonitis //Texas Journal of Medical Science. – 2022.- P. 86-90.
Mухаммадиевa M.И. (2023). Bирус этиологияли жигар циррози беморларида спонтан бактериал перитонит билан асоратланишнинг профилактикаси ва давосини такомиллаштириш//Oriental Renaissance: Innovative, educational, natural and social sciences. -2023.-P.947-953.
Oblokulov. A.R., M.I. Mukhammadieva.(2022). Clinical and biochemical characteristics of liver cirrhosis patients of viral etiology with spontaneous bacterial peritonitis//ACADEMICIA GLOBE: INDERSCIENSE RESEARCH.-2022.- P. 210-216
Sanokulova S.A (2023) Clinical and important diagnostic features in the combination of giardiasis with helminthiasis// European journal of modern medicine and practice. №01 P-23-267
Mukhtorova Shokhida Abdulloevna. (2023). CYTOMEGALOVIRUS INFECTIONS IN CHILDREN WITH PRIMARY AND SECONDARY IMMUNE DEFICIENCIES. Academia Science Repository, 4(06), 23–28.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
